ORNBV Orion Oyj Class B

Orion Corporation: Managers’ transactions – Jari Karlson

Orion Corporation: Managers’ transactions – Jari Karlson

ORION CORPORATION      MANAGERS’ TRANSACTIONS 07 May 2020 at 12.30 EEST



Orion Corporation: Managers’ transactions – Jari Karlson

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Person subject to the notification requirement
Name:Karlson, Jari 
Position:Chief Financial Officer
   
Initial Notification 
Reference number:74370029VAHCXDR7B745_20200507105706_3
   
Issuer
Name:Orion Oyj
LEI:74370029VAHCXDR7B745
   
Transaction details
Transaction date:2020-05-07
Venue:NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction:Disposal
 
Instrument:Share
ISIN:FI0009014377
 
Volume:124
Unit price:47.04000 Euro
Volume:200
Unit price:47.03000 Euro
Volume:100
Unit price:47.03000 Euro
Volume:316
Unit price:47.03000 Euro
Volume:273
Unit price:47.02000 Euro
Volume:72
Unit price:47.01000 Euro
Volume:122
Unit price:47.01000 Euro
Volume:60
Unit price:47.05000 Euro
Volume:20
Unit price:47.05000 Euro
Volume:22
Unit price:47.05000 Euro
Volume:110
Unit price:47.03000 Euro
Volume:5
Unit price:47.08000 Euro
Volume:11
Unit price:47.10000 Euro
Volume:19
Unit price:47.03000 Euro
Volume:17
Unit price:47.02000 Euro
Volume:150
Unit price:47.09000 Euro
Volume:17
Unit price:47.01000 Euro
Volume:55
Unit price:47.08000 Euro
Volume:108
Unit price:47.01000 Euro
Volume:55
Unit price:47.08000 Euro
Volume:294
Unit price:47.14000 Euro
Volume:46
Unit price:47.12000 Euro
Volume:200
Unit price:47.11000 Euro
Volume:100
Unit price:47.11000 Euro
Volume:2
Unit price:47.11000 Euro
Volume:110
Unit price:47.10000 Euro
Volume:68
Unit price:47.10000 Euro
Volume:100
Unit price:47.08000 Euro
Volume:131
Unit price:47.08000 Euro
Volume:107
Unit price:47.07000 Euro
Volume:124
Unit price:47.07000 Euro
Volume:100
Unit price:47.06000 Euro
Volume:100
Unit price:47.05000 Euro
Volume:100
Unit price:47.04000 Euro
Volume:121
Unit price:47.04000 Euro
Volume:113
Unit price:47.01000 Euro
Volume:46
Unit price:47.06000 Euro
Volume:50
Unit price:47.03000 Euro
Volume:45
Unit price:47.04000 Euro
Volume:46
Unit price:47.02000 Euro
Volume:141
Unit price:47.01000 Euro
 
Aggregated transactions
Volume:4000
Volume weighted average price:47.05673 Euro

Orion Corporation

Timo LappalainenOlli Huotari
President and CEO   SVP, Corporate Functions

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo

EN
07/05/2020

Underlying

ORNBVOrion Oyj Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orion Oyj Class B

 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal...

Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal  ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST         Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal  Orion to discontinue development of ODM-105 for insomnia.ODM-105 (tasipimidine) was well tolerated. Detailed results, including safety data, and their assessment are to be finalized. Orion Corporation today announced that its candidate ODM-105 (tasipimidine) did not meet the primary goal in the clinical Phase 2 UNITAS study for the treatment of patients with insomnia. Accor...

September 30, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orionin vaiheen 2 tutkimus ODM-105:llä unettomuuden hoidossa ei saavut...

Orionin vaiheen 2 tutkimus ODM-105:llä unettomuuden hoidossa ei saavuttanut ensisijaista tavoitettaan ORION OYJ        LEHDISTÖTIEDOTE        30.9.2025 KLO 13.00         Orionin vaiheen 2 tutkimus ODM-105:llä unettomuuden hoidossa ei saavuttanut ensisijaista tavoitettaan Orion lopettaa ODM-105:n kehityksen unettomuuden hoitoon.ODM-105 (tasipimidiini) oli hyvin siedetty. Yksityiskohtaisten tulosten, mukaan lukien turvallisuusdata, valmistuminen ja arviointi on vielä kesken. Orion Oyj:n lääkekandidaatti ODM-105 (tasipimidiini) ei saavuttanut ensisijaista tavoitettaan unettomuuspotilaiden h...

September 30, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 September 2025 at 9.00 EEST          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 26 Septembe...

September 30, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        30.9.2025 KLO 9.00         Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan, välillisesti ja rahoitusinstrumenttien kautta omistamien Orionin osakkeiden osuus on 26.9.2025 alittanut viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRoc...

September 30, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025 at 16.30 EEST          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 25 Septemb...

September 26, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch